NASDAQ:FBIOP

Fortress Biotech 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock Insider Trading

Healthcare > Biotechnology

Buy FBIOP

*Your capital is at risk

$6.69

-0.309 (-4.42%)

At Close: Nov 17, 2025

Fortress Biotech 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.67. In total, the insiders bought 26.79M and sold 20K FBIOP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.67
● Buy	26.79M shares
● Sell	20K shares
98% Buy Activity Negligible or No Correlation
Buy Signal High Confidence Nov 10, 2025 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 99.67. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (98% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	2 711 Value: $4K
Oct 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	2 711 Value: $4K
Apr 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	5 000 Value: $6K
Apr 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	5 000 Value: $6K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Klein Dov Director	Director	49 383 Value: $330.4K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Lu Lucy Director	Director	49 383 Value: $330.4K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Harvey Jimmie Director	Director	49 383 Value: $330.4K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Lorenz Kevin Director	Director	49 383 Value: $330.4K
Jan 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Hoenlein Malcolm Director	Director	49 383 Value: $330.4K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Weiss Michael S Executive Vice Chairman	CEO / President	454 153 Value: $3.04M
Jan 01, 2025 Buy	Common stock, par value $0.001 A-Award	Rosenwald Lindsay A Md President, CEO & Chairman	CEO / President	454 153 Value: $3.04M
Jan 01, 2025 Buy	Common stock, par value $0.001 A-Award	Rosenwald Lindsay A Md President, CEO & Chairman	CEO / President	454 153 Value: $3.04M
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Weiss Michael S Executive Vice Chairman	CEO / President	454 153 Value: $3.04M
Jan 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Hoenlein Malcolm Director	Director	49 383 Value: $330.4K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Lorenz Kevin Director	Director	49 383 Value: $330.4K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Harvey Jimmie Director	Director	49 383 Value: $330.4K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Lu Lucy Director	Director	49 383 Value: $330.4K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Klein Dov Director	Director	49 383 Value: $330.4K
Dec 19, 2024 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	1 000 000 Value: $6.75M
Dec 19, 2024 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	1 000 000 Value: $6.75M
Oct 01, 2024 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	2 625 Value: $3K
Oct 01, 2024 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	2 625 Value: $3K
Sep 23, 2024 Buy	Common stock, par value $0.001 P-Purchase	Rosenwald Lindsay A Md President, CEO & Chairman	CEO / President	763 359 Value: $1.40M
Sep 23, 2024 Buy	Warrants to Purchase Common Stock P-Purchase	Rosenwald Lindsay A Md President, CEO & Chairman	CEO / President	763 359 Value: $1.40M
Sep 23, 2024 Buy	Warrants to Purchase Common Stock P-Purchase	Rosenwald Lindsay A Md President, CEO & Chairman	CEO / President	763 359 Value: $1.40M

About Insider Power

Insider Power is a proprietary algorithm developed by Stockinvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT FORTRESS BIOTECH INC.9.375 % CUM CONV PERP RED PFD REGISTERED SHS SERIES A

Fortress Biotech 9.375 % Cum Conv Perp Red Pfd Registered Shs Series A

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UNIT $6.00	4.83%	Nov 04
TBPH $14.14	27.58%	Oct 23
A AMIX $1.12	2.68%	Oct 23
COCO $40.85	11.21%	Oct 23
LAUR $29.55	1.20%	Oct 22

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by